Free Trial Free TrialFree Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Georgia US - United States Signed bill amends state hemp law in significant ways ...
  • Connecticut - United States House bill to amend state cannabis law passes to Senate ...
  • United States DEA and HHS agree on rescheduling of cannabis, now await OMB and public consulta ...
  • United Kingdom FSA committee grants first-ever novel food authorisations for two CBD products ...
  • Germany Amendment to Cannabis Act to be discussed and referred to Health Committee ...
  • Switzerland Initiative seeks constitutional amendment to legalise recreational cannabis ...
  • Ukraine Public consultation open on procedure to buy cannabis seeds for medical reasons ...
  • Ukraine Public consultation open on procedure for transportation of narcotics ...
  • Ukraine Public consultation open on regulation on medical cannabis information system ...
  • Ukraine Public consultation open on procedure for selecting cannabis samples for testing ...
  • Germany Associations asked to comment on draft recreational cannabis bill ...
  • North Dakota - United States State secretary approves petition format for cannabis measure ...
View all
Alerts

CBD-Intel regulatory news in brief, 12th-18th November

Written by || 18th November 2019 || Alerts , Regulatory alerts roundup | Regulation and legislation | GeographiesAsia Belgium California Czech Republic Estonia Europe Florida Germany Illinois Israel Massachusetts Netherlands New York North America Ohio Oregon United Kingdom United States Washington Wisconsin

According to the latest investigation on the outbreak of lung diseases associated with vaping, released on Friday by the CDC, vitamin E acetate was the substance found in all of the samples tested. This and other stories from the US, Europe and Israel
Read more
I'm already a subscriber

Login

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Thanks for getting in touch with us

Please leave your enquiry and we will get back to you within 24 hours


    Sign up to our newsletter

    Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis


      See more


      By signing up you agree to our Privacy Policy.